Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2725 of 3284 entries
View as:

Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations

Phase: N/A Priority: Normal
NCT ID: NCT06040086 Org: User:
Start: 09/22/23 End: 05/22/26 Due: 05/22/27

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Non-squamous NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT06627647 Org: User:
Start: 11/27/24 End: 03/25/30 Due: 03/25/31

Effects of Administration of Fostamatinib on Blood Concentrations of Rifampicin in Healthy Subjects.

Phase: N/A Priority: Normal
NCT ID: NCT01336218 Org: User:
Start: 04/30/11 End: 07/31/11 Due: 07/31/12

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of AZD0780 in Participants With Dyslipidaemia

Phase: N/A Priority: Normal
NCT ID: NCT06834932 Org: User:
Start: 12/06/24 End: 06/18/27 Due: 06/18/28

Durvalumab+ Gemcitabine/Cisplatin (Neoadjuvant Treatment) and Durvalumab (Adjuvant Treatment) in Patients With MIBC

Phase: N/A Priority: Normal
NCT ID: NCT03732677 Org: User:
Start: 11/16/18 End: 06/30/26 Due: 06/30/27

Secondary Adjuvant Long Term Study With Arimidex

Phase: N/A Priority: Normal
NCT ID: NCT00295620 Org: User:
Start: 03/01/04 End: 06/30/17 Due: 06/30/18

Osimertinib With Chemotherapy as First-line Therapy for EGFR Mutation-positive NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT06376084 Org: User:
Start: 07/23/24 End: 02/28/28 Due: 02/28/29

A Ph 1 Study of Epanova® in Healthy Chineses

Phase: N/A Priority: Normal
NCT ID: NCT03574142 Org: User:
Start: 06/04/18 End: 06/27/18 Due: 06/27/19

A Non Interventional Study to Investigating the Ratio of Mis-diagnosed Bipolar Symptoms in Patient With Major Depressive Disorder (MDD)

Phase: N/A Priority: Normal
NCT ID: NCT01344733 Org: User:
Start: 05/31/11 End: 03/31/12 Due: 03/31/13

A Study to Compare the Effects of Exenatide and Sitagliptin on Postprandial Glucose in Subjects With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00477581 Org: User:
Start: 05/31/07 End: 09/30/07 Due: 09/30/08

Immediate Postoperative Adjuvant Hormonal Treatment in High Risk Localised or Locally Advanced Prostate Cancer Patients.

Phase: N/A Priority: Normal
NCT ID: NCT01123434 Org: User:
Start: 04/30/10 End: 08/31/14 Due: 08/31/15

A Study in Healthy Volunteers and Patients With Mild Asthma to Investigate the Safety, Anti-inflammatory Effect of Inhaled AZD0449

Phase: N/A Priority: Normal
NCT ID: NCT03766399 Org: User:
Start: 11/30/18 End: 06/24/21 Due: 06/24/22

Study to Investigate the Safety and Tolerability of AZD8848 in Butyrylcholinesterase Deficient Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01205867 Org: User:
Start: 09/30/10 End: 01/31/12 Due: 01/31/13

Diabetic Retinopathy Candesartan Trials

Phase: N/A Priority: Normal
NCT ID: NCT00252733 Org: User:
Start: 06/30/01 End: 04/30/08 Due: 04/30/09

Open-label, Safety and Efficacy Study of Pulmicort® Turbuhaler® in Japanese Children With Bronchial Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00504062 Org: User:
Start: 10/31/06 End: 10/31/07 Due: 10/31/08

A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD7594 Inhaled Formulation in Healthy Japanese Men

Phase: N/A Priority: Normal
NCT ID: NCT02645253 Org: User:
Start: 01/12/16 End: 04/17/16 Due: 04/17/17

Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Efficacy of AZD2014

Phase: N/A Priority: Normal
NCT ID: NCT01026402 Org: User:
Start: 12/31/09 End: 08/31/14 Due: 08/31/15

Study to Assess the Effect on Glucose Homeostasis of Two Dose Levels of AZD9567, Compared to Prednisolone, in Adults With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT04556760 Org: User:
Start: 11/26/20 End: 06/09/21 Due: 06/09/22

Sicilian Administrative Data Base Study in Acute Coronary Syndrome Patients

Phase: N/A Priority: Normal
NCT ID: NCT01678339 Org: User:
Start: 09/30/12 End: 12/31/12 Due: 12/31/13

Efficacy of Symbicort Versus Its Monocomponents - SPRUCE 80/4.5

Phase: N/A Priority: Normal
NCT ID: NCT00651651 Org: User:
Start: 08/31/02 End: 09/30/03 Due: 09/30/04

AZD3355 Dose-escalation Study in Healthy Males

Phase: N/A Priority: Normal
NCT ID: NCT00757419 Org: User:
Start: 09/30/08 End: 12/31/08 Due: 12/31/09

A Long Term Study to Assess the Safety of Fostamatinib in Patients in Asia With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01640054 Org: User:
Start: 07/31/12 End: 07/31/13 Due: 07/31/14

Centralized Pan-Middle East Survey on the Undertreatment of Hypercholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT01025388 Org: User:
Start: 11/30/09 End: 05/31/10 Due: 05/31/11

A Phase IIa Study Assessing the Effects of AZD1236 on Biomarkers in Chronic Obstructive Pulmonary Disease (COPD) Patients

Phase: N/A Priority: Normal
NCT ID: NCT00758706 Org: User:
Start: 09/30/08 End: 05/31/09 Due: 05/31/10

A First-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD2373 After Single Dose Administration in Healthy Male Subjects of African Ancestry.

Phase: N/A Priority: Normal
NCT ID: NCT04269031 Org: User:
Start: 02/13/20 End: 08/31/21 Due: 08/31/22